Medical School Receives Grant for Hematology Research Training Program
Dr. Greg Vercellotti, professor of Medicine, Division of Hematology, Oncology and Transplantation has received a five-year, $2.3 million T32 grant from the National Heart, Lung, and Blood Institute (NHLBI). This renewal of the T32 grant continues the support of the Hematology Research Training Program at the University of Minnesota Medical School, a specialized research training program designed to train physicians and scientists for careers in academic medicine and hematology-related research.
Now in its 40th year, the Hematology Research Training Program is one of the longest-running, continuously funded training programs supported by the NHLBI and has provided training to more than 120 hematology research scientists since 1976. The initial program was directed by Harry Jacob, M.D., who led the program from 1976 to 1999. The program was subsequently directed by Robert Hebbel, M.D. (2000-2007) and is now directed by Greg Vercellotti, M.D. (2008-present). Although the program has evolved considerably during the past 40 years, the foundation on which the program was built remains the same to identify, recruit and train successful hematology investigators.
You may also like:
U.S. Senator Amy Klobuchar met with University of Minnesota Medical School Alzheimer’s researchers and saw first-hand some of the latest work being done for the disease.
As the opioid crisis continues to intensify, Americans are being urged to get and learn how to use naloxone.
Heroin and prescription opioid abuse is currently a public health emergency in the United States. But researchers from the University of Minnesota Medical School are developing vaccines to ward off opioid addiction.